Cancer is a complex and dynamic foe. The Damon Runyon Board is committed to providing a framework for identifying, mentoring, and funding brilliant young scientists who have the talent and imagination to make paradigm-shifting strides in understanding and disrupting its mechanisms.”

CHAIR

Deborah J. Coleman*

Boston, Massachusetts

* Indicates member serves on the Scientific Committee

Vice Chair, Scientific Programs

William G. Kaelin, Jr., MD*
Sidney Farber Professor of Medicine
Dana-Farber Cancer Institute and
Harvard Medical School
Howard Hughes Medical Institute Investigator
Boston, Massachusetts

 

Vice Chair, Investments and Treasurer

David G. Marshall
Chairman and Chief Executive Officer
Amerimar Realty Company
Philadelphia, Pennsylvania

 


 

Vice Chair, Audit and Secretary

Sanford W. Morhouse, Esq.
Of Counsel
Schulte Roth & Zabel LLP
New York, New York

 


 

Receiving a Damon Runyon Fellowship had a tremendous impact on my scientific career. I also have been fortunate to mentor new Damon Runyon scientists in my lab who have gone on to have exemplary independent careers. Damon Runyon builds generations of scientific leaders and mentors.”

Elaine V. Fuchs, PhD

(Damon Runyon Fellow ‘77-‘79)

Vice Chair, Board Development

Michael L. Gordon*
Chair of Partnership Advisory Board
Angelo Gordon
New York, New York

Vice Chair

David M. Beirne
General Partner
X10 Capital
San Francisco, California

Vice Chair 

Alan M. Leventhal
Chairman and Chief Executive Officer
Beacon Capital Partners, LLC
Boston, Massachusetts

 

Carlos L. Arteaga, MD*
Director of the Harold C. Simmons Comprehensive Cancer Center
Associate Dean of Oncology Programs
Professor of Medicine
The Lisa K. Simmons Distinguished Chair in Comprehensive Oncology
University of Texas Southwestern Medical Center
Dallas, Texas



Steven J. Burakoff, MD*
Dean for Cancer Innovation
Director Emeritus, The Tisch Cancer Institute
Chief, Division of Pediatric Hematology and Oncology
Lillian and Henry M. Stratton Professor of
Professor of Medicine
Professor of Oncological Sciences
Cancer Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

Robyn Coles
President
TRATE Properties LLC
Boston, Massachusetts








Gary E. Erlbaum
President
Greentree Properties
Ardmore, Pennsylvania

 



Thomas J. Fahey, Jr., MD*
Senior Vice President Emeritus
Memorial Sloan Kettering Cancer Center
New York, New York

Buck French
General Partner
X10 Capital
San Francisco, California

Elaine V. Fuchs, PhD*
Head, Laboratory of Mammalian Cell Biology and Development
Rebecca C. Lancefield Professor
The Rockefeller University
Howard Hughes Medical Institute Investigator
New York, New York

Levi A. Garraway,
MD, PhD*

Executive Vice President
Chief Medical Officer and Head of Product Development
Genentech/Roche, Inc.
South San Francisco, California

Richard B. Gaynor, MD*
President and Chief of Research and Development
BioNTech US
Cambridge, Massachusetts

 


 

Damon Runyon is one of the most successful and impactful organizations when it comes to support of the next generation of leaders in cancer research. Our ability to advance the understanding and treatment of cancer depends on the intellectual creativity and firepower of the people doing the research, so I wanted to be a part of ensuring that this organization can continue and grow its remarkable impact.”

Levi A. Garraway, MD, PhD

Todd R. Golub, MD*
Director and Founding Core Institute Member
Broad Institute of MIT and Harvard
Charles A. Dana Investigator in Human Cancer Genetics
Dana-Farber Cancer Institute
Professor of Pediatrics
Harvard Medical School
Cambridge, Massachusetts

Scott Greenstein
President and Chief Content Officer
SiriusXM
New York, New York

 

 

 

 

Steve Hayden
Vice Chairman and Chief Creative Officer (Retired)
Ogilvy & Mather Worldwide
New York, New York

 

 

 

 

Morana Jovan-Embiricos, PhD*
Managing Partner
F2 Capital Ventures LLP
London, United Kingdom

Steven A. Kandarian
Chairman, President and Chief Executive Officer (Retired)
MetLife, Inc
North Palm Beach, Florida

Noah Knauf
General Partner
Bond Capital
San Francisco, California

Gabrielle Layton, PhD
Palo Alto, California

David M. Livingston, MD*
Emil Frei Distinguished Professor of Genetics and Medicine
Harvard Medical School and
Dana-Farber Cancer Institute
Boston, Massachusetts

Richard W. Meier
Director
The Bakewell Foundation
St. Louis, Missouri

John H. Myers
President (retired)
GE Asset Management
Fairfield, Connecticut

Richard J. O’Reilly, MD*
Claire L. Tow Chair, Pediatric Oncology Research
Memorial Sloan Kettering Cancer Center
New York, New York

Andrew S. Rachleff
President and Chief Executive Officer
Wealthfront, Inc.
Palo Alto, California

Meghan Raveis
Managing Director
William Raveis Charitable Fund
Shelton, Connecticut

Michael V. Seiden, MD, PhD*
President
The US Oncology Network
The Woodlands, Texas

Karen D. Seitz
Founder and Managing Director
Fusion Partners Global LLC
New York, New York

In Silicon Valley, we have witnessed brilliant young minds with bold ideas change the world. Damon Runyon makes this happen for cancer research. It identifies top emerging talent and encourages their high risk/high reward ideas. The payoff has been generations of game-changers.”

Andy and Debbie Rachleff

Nancy Simonian, MD*
Chief Executive Officer
Syros Pharmaceuticals, Inc.
Cambridge, Massachusetts

Cynthia Sulzberger
Wellington, Florida

Judy C. Swanson
Hillsborough, California

Nat Turner
Co-Founder and Chief Executive Officer
Co-Founder and Chairman, Flatiron Health
New York, New York

Peter Van Camp
Executive Chairman
Equinix, Inc.
Redwood City, California


James A. Wells, PhD*
Harry Wm. and Diana V. Hind
Distinguished Professor in Pharmaceutical Sciences
Professor, Department of Pharmaceutical Chemistry
University of California, San Francisco
San Francisco, California

© COPYRIGHT DAMON RUNYON. ALL RIGHTS RESERVED